Ho Chih-Ming, Chien Tsai-Yen, Huang Shih-Hung, Lee Bor-Heng, Chang Shwu-Fen
Gynecologic Cancer Center, Department of Obstetrics and Gynecology, Cathay General Hospital, Taipei, Taiwan, ROC.
Gynecol Oncol. 2006 Jul;102(1):54-60. doi: 10.1016/j.ygyno.2005.11.035. Epub 2005 Dec 28.
The aim of this prospective study was to analyze whether integration or high viral loads of human papillomavirus (HPV) is essential for malignant transformation of HPV types 52 and 58 as well as types 16 and 18.
Cervical swabs from 178 consecutive patients, including 81 with invasive cervical cancers and 97 with cervical intraepithelial neoplasias (CIN) II-III, were collected and examined to determine the physical status and viral load of HPV types 16, 18, 52 and 58 DNA using genechip and real-time PCR (polymerase chain reaction) analysis.
In cervical cancer patients, the integrated form of HPV 52 and 58 DNA was found in 25.0% and 12.5% of swabs, respectively; while HPV16 and 18 DNA was found in 82.6% and 100% of swabs, respectively (P < 0.01, for pair-wise comparison of types 16, 18 versus types 52, 58). The viral loads reflected by the amount of E6 for HPV 16, 18, or 52 were significantly increased in invasive cervical cancer compared to CINII-III (P = 0.022 for type 16, P = 0.003 for type18, and P = 0.001 for type 52, respectively). Area under the receiver operating characteristic (ROC) curve for cervical cancer versus CIN II-III was 73.8%, 92.9%, and 88.5% for HPV 16, 18, and 52, respectively, indicating that real-time PCR had good diagnostic value in differentiating cervical cancer from CIN II-III.
Infrequent integration of HPV 52 and 58 DNA in cervical cancer suggests that it is not prerequisite for progression to cervical cancer. High viral loads (E6) of HPV 16, 18, and 52 DNA may be predictive of the transition of CIN II-III to cervical cancer. Our results indicate that both viral DNA physical status and viral loads of HPV are important factors in the carcinogenesis of different HPV types.
本前瞻性研究旨在分析人乳头瘤病毒(HPV)的整合或高病毒载量对于52型和58型HPV以及16型和18型HPV的恶性转化是否至关重要。
收集了178例连续患者的宫颈拭子,其中包括81例浸润性宫颈癌患者和97例宫颈上皮内瘤变(CIN)II-III级患者,采用基因芯片和实时聚合酶链反应(PCR)分析来确定16型、18型、52型和58型HPV DNA的物理状态和病毒载量。
在宫颈癌患者中,分别在25.0%和12.5%的拭子中发现了52型和58型HPV DNA的整合形式;而分别在82.6%和100%的拭子中发现了16型和18型HPV DNA(16型、18型与52型、58型两两比较,P<0.01)。与CINII-III相比,浸润性宫颈癌中由HPV 16、18或52的E6量反映的病毒载量显著增加(16型P = 0.022,18型P = 0.003,52型P = 0.001)。对于宫颈癌与CIN II-III,HPV 16、18和52的受试者操作特征(ROC)曲线下面积分别为73.8%、92.9%和88.5%,表明实时PCR在区分宫颈癌与CIN II-III方面具有良好的诊断价值。
宫颈癌中HPV 52和58 DNA整合不常见,提示其并非进展为宫颈癌的先决条件。HPV 16、18和52 DNA的高病毒载量(E6)可能预示着CIN II-III向宫颈癌的转变。我们的结果表明,HPV的病毒DNA物理状态和病毒载量都是不同HPV类型致癌过程中的重要因素。